Straggler Novavax Still Hopes To Hit Paydirt With Combo Vaccine
Executive Summary
The company announced early data for a combination vaccine against SARS-CoV-2 and influenza, which could provide a revenue opportunity of $2bn.
You may also be interested in...
US FDA To Publish Advisory Committee Timeline For COVID-19 Vaccine In Children Under 5
But CBER Director Peter Marks reiterated to Senators that EUAs cannot be granted for those children until applications are completed and submitted.
J&J Continues Signaling Aggressive M&A Approach To Drive Growth
Johnson & Johnson reported disappointing Q1 sales for its COVID-19 vaccine but called the Carvykti launch solid and discussed plans for further diversification of its multiple myeloma portfolio.
Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas
The company hopes to expand Spikevax’s reach beyond the current approved population while also looking to take the lead in mRNA vaccines in other diseases.